Euro Personalized Medicine Market Analysis and Reports | UK Conference Series

Market Analysis - Euro Personalized Medicine 2017

Market analysis:

Scope and Importance of Personalized Medicine and Genetics:

Scope:  The Scope of the conference is to gather all the Doctors, Researchers, Business Delegates and Scientists to approach and deliver all the attendees about the latest scientific advancements on the respective sphere. This Personalized Medicine Conference is the premier event focusing on understanding individual and organizational behaviour and decision-making related to Pathologists, Geneticists and molecular biology, biotechnology, pharmaceuticals, medicals and academia.

Importance: Conference on Personalized Medicine is a much celebrated conference which basically deals with the latest research and developments in the sphere of genetics and molecular biology. This Conference will provide a perfect platform to all the International mix of leading Research Scholars, and Scientists achieved eminence in their field of study, research academicians from the universities and research institutions, industrial research professionals and business associates along with Ph.D. Students to come and inform all the attendees about the latest scientific advancements on the respective sphere.

Today’s Market Study of Personalized Medicine in USA | Europe | Middle East | Asia Pacific

USA:  The USA Genetics market is poised to reach USD 19.99 Billion by 2020, growing at a CAGR of 9.9% during the forecast period of 2015 to 2020.

Europe:  The Europe genetic testing market is estimated at USD 1.22 billion in 2016, and is projected to reach USD 1.8 billion by 2021, growing with a compound annual growth rate (CAGR) of 8.2% during the forecast period, 2016-2021.

Middle East:  The global Human Genetics identification market was valued at an estimated $419.4 million in 2013 and is expected to grow at a CAGR of 13.9% in the next five years.

Asia pacific: The global gene expression analysis market is projected to reach USD 5.30 Billion by 2020 from USD 3.39 Billion in 2015, at a CAGR of 9.3% from 2015 to 2020. The primary growth engine in this region is China, which is expected to register a growth rate of 13.2% in the forecast period.

Hospitals Associated with PM Research

Various institutes and treatment facilities involved in PM research Center and are intricate in cancer biomarker research all around the world. There are about 3870 hospitals in the world and 275 hospitals in UK which are prominent and working on biomarkers, Cancer, Genomics in PM.

 

Societies and Associations on the topic

British in Vitro Diagnostics Association (BIVDA)

California Life Sciences Association- Molecular Diagnostics

American Board of Clinical Chemistry

Molecular Diagnostics Laboratory

Association for Molecular pathology and

Many more …..

The majority of research is conducted in educational institutions by passionate groups of researches in numerous places throughout the world.

Top universities in Scotland

Edinburgh Napier University

Scotland's Rural College

University of Dundee

University of the West of Scotland

The University of Edinburgh

Robert Gordon University and Many more

Top Universities in World Wide

California Institute of Technology

University of Oxford

Massachusetts Institute of Technology

Imperial College London

Johns Hopkins University and Many more

Top Universities in Edinburgh

Heriot-Watt University

University of Edinburgh

Edinburgh Napier University

Stevenson College, Edinburgh

Edinburgh's Telford College

Edinburgh Theological Seminary

University of Edinburgh College of Science and Many more

 

Industries associated with Diagnostics and Genomics research:

Companies which play an important role in Diagnostics, Genomics and Health care market in UK are,

  • Omega Diagnostics Ltd
  • Genestack
  • DiscoveRx
  • Parexel
  • TrakCel
  • Horizon Discovery
  • Kasocio and Many more

Companies from all over the world are,

  • 20/20 Gene Systems
  • Curetis
  • IntegraGen
  • Nuclea Biotechnologies
  • ProteoMediX                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

                                                                                                                                                                  

 

 

Target Audience:

 

                                                                                                                                                                                      

About Conference

We would like to solicit your gracious presence at the upcoming 6th European Conference on Predictive  Preventive and Personalized Medicine & Molecular Diagnostics during September 14-15,  in Edinburgh, Scotland

WHAT IT IS?

Preventive Medicine

Preventive healthcare consists of measures taken for disease prevention, as opposed to disease treatment. A medicine or other treatment designed to prevent disease or ill healths. which are affected by environmental factors, genetic predisposition, disease agents, and lifestyle choices.

Predictive Medicine

The branch of medical science or practice concerned with the prediction of the occurrence or course of disease in individual patients, now especially using genetic information.

Molecular diagnostics

Molecular diagnostics method used to analyse biological markers in the genome and proteome and by applying molecular biology to medical testing. This technique is used to diagnose and monitor disease, detect risk, and decide which therapies will work best for individual patients.

Personalized medicine

Personalized medicine is a medical practice that separates patients into different groups with medical decisions, practices, interventions and products being tailored to the individual patient based on their predicted response and risk of disease.

Personalized Medicine is a individualized treatment which implies the solution of particular medications and therapeutics. Personalized Medicine 2017 highlights the topic "Unleashing the novel approaches in advancing Personalized Medicine" alongside the logical system clears an approach to assemble visionaries through the exploration talks and presentations. A definitive mission of the meeting is to advance numerous interesting the Novel Approaches and Innovations in customized prescription and social insurance, serves a motivation for the progression of Molecular Diagnostics, a brief talk on Protein Biomarkers, extraordinary spotlight on Genetics Informed Personalized Immunotherapy and Stem Cells Therapy as the Future of Personalized Medicine. Customized Medicine guarantees numerous restorative advancements, and can possibly change the way medications are found and utilized.

Conference series LLC is devotedly involved in conducting 300+ Conference series LLC  Every Year across Europe, USA (Baltimore, Chicago, Las Vegas, Philadelphia, and San Antonio) and almost all other parts of the world with support from 1000 more scientific societies and Publishes 400+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

Personalized medicine therapeutics and companion diagnostic market have huge opportunities for growth in healthcare and will improve therapeutic effectiveness and reduce the severity of adverse effects approach to drug therapies. Personalized cancer medicine is self-made samples of translating cancer genetics into medical. There is a huge contribution of Genomic medicine by revealing genomic variations; have an effect on health, sickness and drug response. Biomarker also play vital role in the biological characteristic which can be molecular, anatomic, physiologic and chemical change drug development research which turns biomarkers into companion diagnostics.